Final decision on 2G pricing within 3 months

TRAI recommendation of 'one-time' entry fee for additional spectrum beyond 6.2 Mhz also on anvil

PTI | March 29, 2011



The Telecom Ministry will take a final decision on 2G spectrum pricing and on those holding airwaves beyond contracted limit of 6.2 Mhz, based on recommendations of TRAI, within next three months before seeking Telecom Commission's approval.

"Decision on 2G spectrum pricing is expected in next 3 months. DoT internal committee is finalising it. After we get it we will send the same to Telecom Commission," Department of Telecommunications (DoT) Secretary R Chandrasekhar told reporters here.

Last month, telecom regulator Trai had recommended over six-fold increase in the spectrum price to Rs 10,972.45 crore for a pan-India license with 6.2 Mhz spectrum as compared to Rs 1,658 crore now.

In fact the regulator had classified valuation of spectrum in two categories. There are different prices for spectrum up to contracted limit of 6.2 Mhz and for additional airwaves.

The Telecom Regulatory Authority of India (TRAI) had also recommended 'one-time' entry fee for additional spectrum beyond 6.2 Mhz. The spectrum price varies from circle to circle in both categories.

Replying to a question on the cancellation of license of Swan Telecom (now Etisalat DB), Chandrasekhar said,"No decision on cancellation of licenses of Swan has been taken so far, any decision will be taken by end of April only."

The government had sent a show-cause notice to Etisalat DB asking it to explain why its licences in Delhi and Mumbai circles should not be cancelled for missing rollout obligations.

The telecom department had also issued a notice to Aditya Birla company Idea Cellular for cancellation of 2G licence in Punjab.

The notice to Etisalat DB came after the department had collected over Rs 300 crore in penalties from most new operators for not starting services within the stipulated time after getting the licences and spectrum.
 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter